Stay updated on Ociperlimab, Tislelizumab, Chemotherapy in Metastatic NSCLC Clinical Trial

Sign up to get notified when there's something new on the Ociperlimab, Tislelizumab, Chemotherapy in Metastatic NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ociperlimab, Tislelizumab, Chemotherapy in Metastatic NSCLC Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The Record History now lists the latest revision as v3.5.4, replacing the previous v3.5.3. This reflects an update to the record's metadata without changing the underlying study data.
    Difference
    0.1%
    Check dated 2026-05-16T09:20:19.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page’s displayed UI revision label was updated from v3.5.2 to v3.5.3, reflecting a software/version change rather than a change to the underlying clinical trial record.
    Difference
    0.1%
    Check dated 2026-04-24T16:50:07.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    A new revision entry v3.5.2 was added. The existing revision entry v3.5.0 was removed.
    Difference
    0.1%
    Check dated 2026-04-17T13:45:39.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    Revision history now includes v3.5.0; the v3.4.3 entry was removed.
    Difference
    0.1%
    Check dated 2026-03-19T20:42:42.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    The history now shows Revision: v3.4.3 and no longer lists Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-12T17:59:42.000Z thumbnail image
  8. Check
    94 days ago
    Change Detected
    Summary
    A new site-wide revision entry (Revision: v3.4.2) was added to the history, and an older notice (Revision: v3.4.1) was removed; no study-specific content appears to be affected. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.7%
    Check dated 2026-02-11T09:22:20.000Z thumbnail image

Stay in the know with updates to Ociperlimab, Tislelizumab, Chemotherapy in Metastatic NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ociperlimab, Tislelizumab, Chemotherapy in Metastatic NSCLC Clinical Trial page.